[ad_1]
“Chinese Vaccines Authorized for Conditional Sale Starting Next Week”
China, the general public also received a test request … “Demand survey dimension”
Chinese health authorities “retain antibodies for more than 6 months if vaccinated”
“The Chinese vaccine does not have serious side effects, but recommends 30 minutes to stay in the hospital”
[앵커]
With the intensification of vaccination competition, China is also expected to grant official marketing licenses for domestic vaccines starting next week. We started accepting vaccination requests from the public, and correspondent Kang Seong-woong reports in Beijing. China’s vaccine countermeasures, which establish a policy to inoculate 50 million people before the New Year holidays next year, are accelerating. China’s health authorities are expected to issue official marketing authorizations for the domestic vaccines starting next week. Once the release is conditionally approved, the official license is expected to take place around April next year. Medical personnel and police officers are also beginning to receive vaccination requests from non-preferred individuals. Tangyuan County, Heilongjiang Province, has requested some 250,000 former residents since the 15th. It’s kind of a demand survey, but the actual vaccine is expected to be available early next year when the vaccine becomes available. Chinese health officials have announced that those who received the homemade vaccine maintained the antibodies for at least six months. In March, a participant in a clinical trial was told that the antibodies stayed for 9 months. Although there were no serious side effects in the test, it was also revealed that it was best to stay in the hospital for 30 minutes immediately after vaccination. China’s vaccine production capacity is expected to exceed 600 million doses per year and more than 1 billion doses next year. China has yet to officially announce the efficacy and final results of its vaccine trials, but it is highly likely that some of it will be released before conditional marketing approval next week. YTN Sungwoong Kang in Beijing[[email protected]]is.
